targomed

Targomed GmbH is a German biotechnology and personalized medicine company specializing in individualized cancer therapy and advanced diagnostics. The company is best known for its Maintrac method, a proprietary platform used for the identification, quantification, and characterization of circulating tumor cells (CTCs) to monitor treatment efficacy and disease progression in real-time. Targomed provides a suite of services including molecular profiling and chemosensitivity testing, which assist clinicians in selecting targeted therapies tailored to the specific biological profile of a patient's tumor. Based in Kassel, the company operates as a specialized center for precision oncology and immunotherapy monitoring, aiming to optimize clinical outcomes through a personalized medicine approach.